Week in Review: Evolution of breast AI | Cadix controversy continues | Sustainable angiography

Dear AuntMinnieEurope Member,

Currently, there are 15 companies with over 20 AI products available on the European market, all CE-marked and clinically approved for their intended use, wrote Kicky van Leeuwen, PhD, who's closely monitored the development of deep learning over the past decade.

When it comes to data on AI, van Leeuwen is a recognized source. Don't miss her expert analysis of the current and future status of breast AI.

Many readers will recall our coverage in June 2024 about the suspension and subsequent termination of the radiologists at ZNA Cadix Hospital. This was our fifth most popular story of 2024 (top 10 list to follow next week). The controversy has ignited again in the Belgian media.

On the final day of RSNA 2024, German researchers presented their findings from an important study about how to make angiography more sustainable. Sustainability will be the central theme of ECR 2025, which begins on 25 February, so this presentation is very timely indeed.

The vast technical exhibition at RSNA always acts as a barometer of the medical imaging industry. In an enlightening eight-minute video interview, Steve Holloway provides a neat summary of the main market trends he spotted during the congress.

Women have often been underrepresented in cardiovascular research, and few studies have addressed the issue of coronary risk focused on clinical and imaging outcomes in women alone. A Spanish team has addressed this problem. Read more here.

Philip Ward
Editor in Chief
AuntMinnieEurope.com

Page 1 of 1264
Next Page